Search
Enter keywords, a title or a report id number below.
Your Search for 'OTC Pharmaceuticals - UK - A Snapshot (2010)' returned 35 results - Page 1 of 2
Sort by
Sorted by
Rank
Top-Bottom
-
Pharmaceuticals - Global Outlook
Global Industry Analysts, Inc, Jan 2012 , Pages: 443Markets Independently Analyzed with Annual Sales Figures in US$ Billion for Years 2010 through 2015 6 Table 4: World 5-Year Perspective for Prescription Pharmaceuticals by Therapeutic Class ... -
PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013
Cambridge Healthtech Institute, Jun 2012Pharma R&D Spend (EvaluatePharma) Top 20 Companies by Pharma R&D Spend in 2011 (EvaluatePharma) Top 20 Companies by Pharma R&D Spend as a % of Pharmaceutical Revenues 2011 vs. 2010 (EvaluatePharma) Top ... -
United Kingdom Pharmaceuticals and Healthcare Report Q4 2010
Business Monitor International, Oct 2010 , Pages: 103United Kingdom Pharmaceuticals and Healthcare Report Q4 2010 In Q410 Pharmaceuticals & Healthcare Business Environment Ratings, the Western Europe region scored an average total of 64.5 out of 100 ... -
United Kingdom Pharmaceuticals and Healthcare Report Q3 2010
Business Monitor International, Jul 2010 , Pages: 113United Kingdom Pharmaceuticals and Healthcare Report Q3 2010 Business Monitor International's United Kingdom Pharmaceuticals and Healthcare Report provides industry professionals and strategists ... -
United Kingdom Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Jan 2010 , Pages: 99United Kingdom Pharmaceuticals and Healthcare Report Q1 2010 The United Kingdom Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts ... -
Nigeria Pharmaceuticals and Healthcare Report Q1 2011
Business Monitor International, Nov 2010 , Pages: 96challenging but promising pharmaceutical market. They expect combined sales of prescription drugs and over-the-counter (OTC) medicines to increase from NGN84.26bn (US$564mn) in 2009 to NGN94.25bn (US$633mn) in ... -
Bahrain Pharmaceuticals and Healthcare Report Q3 2011
Business Monitor International, Jun 2011 , Pages: 91epidemiological factors push the authorities towards a path of cost-containment. Headline Expenditure Projections - Pharmaceuticals: BHD63mn (US$168mn) in 2010 to BHD69mn (US$183mn) in 2011; +9.1% in both local ... -
Bausch & Lomb Incorporated Market Share Analysis
GlobalData, Sep 2011 , Pages: 145Incorporated’s company shares (in Revenues) information for all the key countries the company has presence in – Australia, India, Japan, China, Spain, Germany, Italy, United Kingdom, France, Canada, United States ... -
Switzerland Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Jan 2012 , Pages: 85Projections - Pharmaceuticals: CHF5.88bn (US$5.64bn) in 2010 to CHF5.73bn (US$6.71bn) in 2011; -2.6% growth in local currency terms and +19.08% in US dollar terms. - Healthcare: CHF59.54bn (US$57.09bn) in ... -
Hong Kong Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Dec 2011 , Pages: 91significant opportunities for the manufacturers and suppliers of medicines for the treatment of chronic diseases. Headline Expenditure Projections - Pharmaceuticals: HKD7.98bn (US$1.03bn) in 2010 to ... -
Argentina Pharmaceuticals and Healthcare Report Q4 2010
Business Monitor International, Aug 2010 , Pages: 89Argentina Pharmaceuticals and Healthcare Report Q4 2010 Business Monitor International's Argentina Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ... -
Global Biopharma Outlook 2011
MP Advisors, Jan 2011 , Pages: 3911: Increased Sales Force Breakup Generic Formulations - Growth From All the Geographies - US Generics - UK Generics - Generic Coartem Sales to WHO nations Branded Formulations - Russia Still ... -
Philippines Pharmaceuticals and Healthcare Report Q3 2010
Business Monitor International, May 2010 , Pages: 100Philippines Pharmaceuticals and Healthcare Report Q3 2010 The Philippines Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical ... -
Kenya Pharmaceuticals and Healthcare Report Q1 2009
Business Monitor International, Jan 2009 , Pages: 66Indigenous Producers Dawa Limited Universal Corporation Limited Shelys Pharmaceuticals Regal Pharmaceuticals High Chem East Africa Country Snapshot: Kenya Demographic Data Section 1: Population Table ... -
Herbal Supplements and Remedies - Global Strategic Business Report
Global Industry Analysts, Inc, Mar 2013 , Pages: 552, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these ... -
Bangladesh Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Nov 2009 , Pages: 60Bangladesh Pharmaceuticals and Healthcare Report Q1 2010 Business Monitor International's Bangladesh Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate ... -
Egypt Pharmaceuticals and Healthcare Report Q4 2009
Business Monitor International, Aug 2009 , Pages: 86Bristol-Myers Squibb (BMS)’s Egyptian branded generics business, in July 2009 UK pharmaceutical major GlaxoSmithKline (GSK) paid US$23.2mn for a portfolio of 13 branded generics sold in five other Middle ... -
Canada Pharmaceuticals and Healthcare Report Q1 2012
Business Monitor International, Dec 2011 , Pages: 91effective. Headline Expenditure Projections - Pharmaceuticals: CAD25.94bn (US$25.19bn) in 2010 to CAD26.30bn (US$27.39bn) in 2011; +1.3% growth in local currency terms and +8.7% growth in US dollar terms ... -
Teva Pharmaceutical Industries Limited - Product Pipeline Review - H2 2011
Global Markets Direct, Nov 2011 , Pages: 431Details Asset Transactions Yissum Research Sells Asthama Treatment Rights To Teva Pharmaceutical SICOR Pharmaceuticals Reacquires US Rights Of Calcitriol From AAIPharma IVAX Acquires ... -
Bayer AG - Product Pipeline Review - H2 2011
Global Markets Direct, Nov 2011 , Pages: 478, 2011: Health Canada Provides Update On Trasylol May 20, 2010: Bayer And Onyx Announce Presentation Of Nexavar Data At 46th American Society Of Clinical Oncology Annual Meeting May 19, 2011: Ardea ...
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
